Literature DB >> 20371963

B cell aplasia and hypogammaglobulinemia after carbamazepine treatment.

Tatsuya Yamamoto1, Tomoyuki Uchiyama, Hirokatsu Takahashi, Keiichi Himuro, Kazuaki Kanai, Satoshi Kuwabara.   

Abstract

Although immunosuppressive effects of antiepileptic drug are well known, serious complications of antiepileptic drug are rare. We report a case of hypogammaglobulinemia associated with aplasia of B lymphocytes after carbamazepine treatment. Despite repeated intravenous immunoglobulin replacement therapy, this condition persisted for more than three months. The present case suggested that routine monitoring of the blood cell count and serum levels of immunoglobulin are important in patients treated with carbamazepine, and a lymphocyte subpopulation study is valuable in cases of hypogammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371963     DOI: 10.2169/internalmedicine.49.3087

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Carbamazepine-induced agammagloblinaemia clinically mimicking diffuse panbronchiolitis.

Authors:  Chisho Hoshino; Tadashige Hoshi
Journal:  BMJ Case Rep       Date:  2011-02-16

2.  Duration of remission phase of 36 Korean patients with glossopharyngeal neuralgia.

Authors:  Myong-Soo Kang; Do-Wan Kim; Sung-Min Kim; Chan Kim; Young-Ki Kim
Journal:  Korean J Anesthesiol       Date:  2013-04-22

3.  Carbamazepine-induced interstitial pneumonitis associated with pan-hypogammaglobulinemia.

Authors:  Daniel Gonçalves; Rute Moura; Catarina Ferraz; Artur Bonito Vitor; Luísa Vaz
Journal:  Respir Med Case Rep       Date:  2012-01-24

4.  B cell aplasia and hypogammaglobulinemia associated with levetiracetam.

Authors:  Hulya Ozdemir; Sua Sumer; Hakan Karabagli; Gokhan Akdemir; A Zafer Caliskaner; Hasibe Artac
Journal:  Ann Saudi Med       Date:  2018-01-09       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.